William Frye

Jan 23, 2024 | onyamagazine.com | Sandi Sieger |William Frye

Victorians remain faithful to electricity suppliers despite the increased hit to the hip pocket, with a recent survey finding one in five consumers know there are better electricity deals on offer, but have not acted to take advantage. The survey of 1000 Victorian consumers was commissioned by Dodo Power and Gas and also found that many of us simply turn a blind eye when it comes to our electricity bills, with almost half of respondents saying they did not know if they were getting the best deal.

Dec 14, 2023 | onlinelibrary.wiley.com | William Frye |Kimberly Swan MS |Lauren Gardner

Corresponding Author William S. Frye PhD, BCB, ABPP Pediatric Psychologist Psychology Department, Johns Hopkins All Children's Hospital, 880 6th Street South, Suite 420, St. Petersburg, FL, 33701 Address correspondence to: William Frye, Pediatric Psychologist, ([email protected]), Psychology Department, Johns Hopkins All Children's Hospital, 880 6th Street South, Suite 420, St. Petersburg, FL 33701. Search for more papers by this author

Apr 14, 2023 | pediatricnursing.org | Molly Cole |William Frye |Judy Risko |Carrie Hall

Highlights•Parents challenged in functioning/parenting due to having a child with chronic pain•Parental survey responses provide insight into their first-hand experience. •How pediatric and adolescent chronic non-cancer pain impacts entire family unit•Providers need to understand parental perceptions and experiences to inform care. AbstractPurposeTo explore parental experiences in personal functioning and parenting associated with having a child experiencing chronic non-cancer pain.

Feb 15, 2023 | biorxiv.org | Robert W. Robey |Christina M. Fitzsimmons |Wilfried M. Guiblet |William Frye

New Results doi: https://doi.org/10.1101/2022.10.07.511310 AbstractHistone deacetylase inhibitors (HDACis) are part of a growing class of epigenetic therapies used for the treatment of cancer. While elevated levels of the efflux pump P-gp are associated with in vitro resistance to romidepsin, this mechanism does not translate to the clinic.